![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » MERCK FILES APPEAL IN TEXAS CASE
MERCK FILES APPEAL IN TEXAS CASE
September 22, 2006
More than a year after losing the first trial over its withdrawn painkiller Vioxx, drugmaker Merck & Co. is appealing a court judgment that awarded $26.1 million to the plaintiff.
BusinessWeek (http://www.businessweek.com/ap/financialnews/D8K9I6H00.htm)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct